NCT04601961 Effects of TIVA Versus Inhalational Anaesthesia on Circulating Tumour Cells in Hepatocellular Carcinoma Patients Status UNKNOWN Phase NA
NCT04597970 TACE Plus HAIC With Oxaliplatin and Raltitrexed for BCLC Stage C HCC Status UNKNOWN Phase PHASE2
NCT04595864 Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation Status RECRUITING Phase PHASE3
NCT04587739 Neoadjuvant Hypofractionated Stereotactic Body Radiation Therapy Prior to Surgery for Hepatocellular Carcinoma: a Feasibility Study. Status RECRUITING Phase PHASE1
NCT04580485 INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04576572 Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma Status COMPLETED Phase N/A
NCT04573881 The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK) Status ACTIVE_NOT_RECRUITING Phase NA
NCT04572633 The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy Status ACTIVE_NOT_RECRUITING Phase NA
NCT04569799 Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE Status COMPLETED Phase PHASE4
NCT04567615 A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors Status COMPLETED Phase PHASE2
NCT04566393 Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies Status AVAILABLE Phase N/A
NCT04564313 Safety and Efficacy of Camrelizumab (Anti-PD-1 Antibody) in Recurrent HCC After Liver Transplantation Status UNKNOWN Phase PHASE1
NCT04563338 An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04562428 The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial Status COMPLETED Phase PHASE4
NCT04560894 SCT-I10A Plus SCT510 Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT04559607 TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma Status ACTIVE_NOT_RECRUITING Phase NA
NCT04555265 Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation Status COMPLETED Phase NA
NCT04553458 Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma Status COMPLETED Phase N/A